US Patent 7355018 Modified IGF1 polypeptides with increased stability and potency
Patent 7355018 was granted and assigned to Regeneron Pharmaceuticals, Inc. on April, 2008 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7355018 Modified IGF1 polypeptides with increased stability and potency
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.